Natco Pharma Receives Demand Notice from NPPA Regarding Overcharging for Two Drugs
Natco Pharma Limited has received a Demand Notice from the National Pharmaceutical Pricing Authority (NPPA) concerning alleged overcharging for two of its drugs. The notice, received on May 12, 2026, mandates the deposit of a specific amount covering overcharge, penalties, and interest.The demand notice was issued under paragraph 15 of the Drugs Price Control Order, 2013 (DPCO). The authority alleges overcharging for two drugs during the period spanning April 2023 to November 2023.
According to the details provided, the NPPA has directed the company to deposit a total of ₹ 4,92,25,923/-.
The key details of the notice are summarized below:
| Particulars | Details |
|---|---|
| Authority | National Pharmaceutical Pricing Authority, New Delhi |
| Nature of Action | Demand Notice issued under para 15 of Drugs Price Control Order, 2013 (DPCO) |
| Amount Demanded | ₹ 4,92,25,923/- (Includes overcharge amount, penalty, and interest) |
| Date of Notice | May 12, 2026 |
| Allegation | Overcharging for 2 drugs covering the period between April 2023 and November 2023 |
In assessing the impact of the notice, the company stated that there is no material impact on its financial, operational, or other activities.
NATCOPHARM Stock Price Movement
Today, Natco Pharma Limited shares edged higher, settling at ₹1204.4, marking a solid gain of 2.98% for the session. Trading was active throughout the day, with the stock trading within a range of ₹1154.5 to ₹1209 on a total volume of 534,977 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.